---
schema_version: "secwatch.filing_event.v1"
accession: "0001447028-22-000051"
form_type: "8-K"
ticker: "ABUS"
cik: "0001447028"
company_name: "Arbutus Biopharma Corp"
filed_at: "2022-10-24T23:59:59+00:00"
generated_at: "2026-06-23T01:37:02.382357+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Arbutus Biopharma appoints Mike McElhaugh as COO effective Nov 1, 2022; salary to $460,000

## Summary
- Mike McElhaugh promoted from Chief Business Officer to Chief Operating Officer, effective November 1, 2022.
- Annual base salary increased to $460,000 under third amendment to existing employment agreement.
- McElhaugh has been with Arbutus since 2014 and was a co-founder of OnCore Biopharma acquired by Arbutus in 2015.
- No other changes to employment terms; no family relationships or transactions requiring disclosure.

## SEC filing metadata
- accession: 0001447028-22-000051
- form_type: 8-K
- ticker: ABUS
- cik: 0001447028
- company_name: Arbutus Biopharma Corp
- filed_at: 2022-10-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1447028/000144702822000051/0001447028-22-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1447028/000144702822000051/abus-20221018.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001447028-22-000051
- JSON: https://secwatch.observer/filing/0001447028-22-000051.json
- Plain text: https://secwatch.observer/filing/0001447028-22-000051.txt

## Key facts
- Executive change
  Mike McElhaugh was appointed as Chief Operating Officer at Arbutus Biopharma Corp.
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On October 18, 2022, the Board of Directors (the “Board”) of Arbutus Biopharma Corporation (the “Company”) appointed Mike McElhaugh, age 48, as the Company’s Chief Operating Officer, effective as of November 1, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1447028/000144702822000051/0001447028-22-000051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.